Archives: Questions And Answers
Is there a positive side to where MFG is currently trading ?
Thank you as usual for your reports. As you are aware ESS is in the final stages of a takeover/buyout. The agreed offer is 50 cents/share. What could be the investment logic of buyers offering 51 cents at this late stage? As an agreed shareholder awaiting my cheque in May am I missing something?
Can I have your thoughts on BVS following the capital raise which has seen its share price halve. Also do you like JEPI as an income stock? Thanks
Hi James
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products, NVO has two business segments – diabetes care and biopharmaceuticals. Of particular interest is the growth NVO’s diabetes and obesity products in the USA.
Is this a stock you have considered for the international portfolio?
Hi James and Team,
Hi James and the Team,
Continue to find your service stimulating and essential daily reading. Just renewed for 2 more years – thank you!